Microsatellite-Stable Tumors With High Mutational Burden Benefit From Immunotherapy

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-19-0149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

High TMB Predicts Immunotherapy Benefit in NSCLC

Cancer Discovery
Oncology
2018English

Stable COPD: Predicting Benefit From High-Dose Inhaled Corticosteroid Treatment

Yearbook of Medicine
2007English

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors

Clinical and Translational Gastroenterology
Gastroenterology
2020English

Immunotherapy and Patients Treated for Cancer With Microsatellite Instability

Bulletin du Cancer
OncologyRadiologyCancer ResearchNuclear MedicineHematologyImagingMedicine
2017English

Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens

JAMA network open
Medicine
2020English

Testing Tumors for Microsatellite Instability

European Journal of Human Genetics
Genetics
1999English

P2.04-14 Tumor Mutational Burden Assessed by a Targeted NGS Assay Predicts Benefit From Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tumor Mutational Burden (TMB) Standardization Initiatives: Recommendations for Consistent TMB Assessment in Clinical Samples to Guide Immunotherapy Treatment Decisions

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy